NSEUpdates17h ago · 14 Oct 2026, 06:46 pm

Updates

Bliss GVS Pharma Limited · BLISSGVS

✦ AI SummaryPromoter Reclassif.

Bliss GVS Pharma Limited has informed the Exchange regarding re-classification from the promoter and promoter group category to the public category, following the consummation of a transaction and completion of an open offer.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk6/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bliss GVS Pharma Limited has informed the Exchange regarding 'Disclosure Submitted to Stock Exchanges on September 28, 2026 under Regulation 31A(10) of the SEBI Listing Regulations in relation to re-classification from the promoter and promoter group category to the public category. '.

Attachments (1)

📄

BLISSGVS_14102026184622_Disclosure_Reg_30_LODR__NewPromoterGroup.pdf

pdf

Download →
View document text
October 14, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"). Ref: Disclosure Submitted to Stock Exchanges on September 28, 2026 under Regulation 31A(10) of the SEBI Listing Regulations in relation to re-classification from the “promoter and promoter group” category to the “public” category. Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that, consequent upon the consummation of the transaction contemplated under the Share Purchase Agreement dated May 23, 2026 (“SPA”), read with the relevant transaction documents, on September 28, 2026, and completion of the open offer in accordance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited acquired control of Bliss GVS Pharma Limited (“Company”) and classified as Promoters of the Company. Consequent to the aforesaid transaction and the change in control of the Company, the Board of Directors of the Company, at its meeting held on September 28, 2026, took note of the reclassification of the erstwhile Promoters and Promoter Group from the “Promoter and Promoter Group” category to the “Public” category in accordance with Regulation 31A(10) of the SEBI Listing Regulations. Accordingly, the updated list of Promoters and Promoter Group of the Company, pursuant to the aforesaid transaction, is set out below: No. Entity Category 1 Anupam Rasayan India Limited Promoter 2 Mates Visa Consultancy Pvt. Ltd. Promoter 3 Kiran Pallavi Investments LLC Promoter Group 4 Jainam Intermediates Pvt. Ltd. Promoter Group 5 ARIL Transmodal Logistic Pvt. Ltd. Promoter Group 6 ARIL Fluorospeciality Pvt. Ltd. Promoter Group 7 Anupam Japan GK Promoter Group 8 Anupam Europe AG Promoter Group 9 Anupam USA, LLC Promoter Group 10 Anupam General Trading FZE Promoter Group 11 Doriath S.A.R.L. Promoter Group 12 Kansas HoldCo Inc. Promoter Group 13 Kansas HoldCo 1, Inc. Promoter Group 14 Jayhawk Fine Chemicals Corporation Promoter Group 15 Tanfac Industries Limited Promoter Group Kindly take the above information on your record and acknowledge. Thanking you, Yours Faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary & Compliance Officer